In a 11-page document dated Sept 22, Janet Woodcock MD, director for the Center for Drug Evaluation and Research, explains why she decided to allow Avandia to continue to be on the market.
在一份标注日期为9月22号的长达11页的文件中,作为药品评估与研究中心的负责人,Janet Woodcock博士解释了为什么她决定允许文迪雅继续在市场上流通。
Janet Woodcock , head of the FDA's Center for Drug Evaluation and Research. Other approved ITP treatments include steroids, immune-suppressing drugs or surgery to remove the spleen.
其他被认可的治疗免疫性血小板减少性紫癜病的手段包括:甾体类药物,免疫抑制剂类药物,或者通过外科手术切除患者的脾脏。
Janet Woodcock , head of the FDA's Center for Drug Evaluation and Research. Other approved ITP treatments include steroids, immune-suppressing drugs or surgery to remove the spleen.
其他被认可的治疗免疫性血小板减少性紫癜病的手段包括:甾体类药物,免疫抑制剂类药物,或者通过外科手术切除患者的脾脏。
应用推荐